Small

Zacks Small Cap Research – MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT FDA Response to 510(k) Filing On October 6, 2024, Monogram (NASDAQ:MGRM) announced it had received an Additional Information Request (“AIR”) from the U.S. Food and Drug Administration (“FDA”) on September 30, 2024, regarding its 510(k) premarket filing submission for the semi-active mBôs TKA System. … Read more

French economy sees small boost from the Olympics but outlook remains gloomy – Go Health Pro

by
French economy sees small boost from the Olympics but outlook remains gloomy – Go Health Pro

Economy, Finance and Industry Minister Antoine Armand and Prime Minister Michel Barnier at the Elysée Palace, Paris, October 15, 2024. JULIEN MUGUET FOR LE MONDE The legacy of the Olympic and Paralympic Games has a lasting impact beyond just sports facilities and urban developments; it will also be reflected in economic growth figures. The Olympics are … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

by

NASDAQ:GRCE | NASDAQ:ACST Since the recording of this interview, the company has changed its name to Grace Therapeutics and is now trading under NASDAQ:GRCE. John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name’s John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Dror Bashan, President & CEO of Protalix Biotherapeutics, and John Vandermosten, Senior Analyst at Zacks SCR – Go Health Pro

by

NYSE:PLX John Viglotti: Hello, and welcome to Virtual Investor Conferences. My name is John Viglotti, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you joined us for our next presentation from Protalix Biotherapeutics. Their session will be moderated by John Vandermosten. He’s the Senior Biotechnology Analyst with … Read more

Zacks Small Cap Research – OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, Interim CEO & CFO, and Steven LaRosa, MD, Chief Medical Officer, of Aethlon Medical Inc., with Marla Marin, Senior Analyst at Zacks SCR – Go Health Pro

by

NASDAQ:AEMD Anthony Krause: Hello and welcome to Virtual Investor Conferences. My name is Anthony Krause, and on behalf of OTC Markets and our co-host, Zacks Small Cap Research, we’re very pleased you have joined us for our next live presentation from Aethlon Medical. Their session will be moderated by Marla Marin, senior Analyst at Zacks … Read more

x